Kayne Anderson Rudnick Investment Management LLC lowered its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 1.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,237,972 shares of the company's stock after selling 42,022 shares during the period. Kayne Anderson Rudnick Investment Management LLC owned 4.90% of Azenta worth $111,899,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of the stock. Lord Abbett & CO. LLC bought a new stake in Azenta in the fourth quarter valued at about $47,350,000. Conestoga Capital Advisors LLC increased its holdings in Azenta by 65.0% in the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company's stock valued at $78,894,000 after buying an additional 621,830 shares during the last quarter. Norges Bank bought a new stake in shares of Azenta in the 4th quarter valued at approximately $25,403,000. Schroder Investment Management Group increased its holdings in shares of Azenta by 46.7% in the 4th quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company's stock valued at $70,183,000 after acquiring an additional 447,292 shares during the last quarter. Finally, Marshall Wace LLP bought a new stake in shares of Azenta in the 4th quarter valued at approximately $20,469,000. Institutional investors and hedge funds own 99.08% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have recently weighed in on AZTA. TD Cowen upgraded Azenta to a "hold" rating in a report on Thursday, February 27th. Needham & Company LLC lowered their price target on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a report on Wednesday, May 7th. Finally, Evercore ISI boosted their price target on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th.
Get Our Latest Stock Report on Azenta
Azenta Trading Down 2.2%
AZTA traded down $0.62 during trading on Wednesday, reaching $27.10. 667,023 shares of the company were exchanged, compared to its average volume of 693,184. The stock has a market cap of $1.24 billion, a P/E ratio of -9.09 and a beta of 1.64. The firm has a 50 day moving average of $28.65 and a 200 day moving average of $40.72. Azenta, Inc. has a 52 week low of $23.91 and a 52 week high of $63.58.
Azenta (NASDAQ:AZTA - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 EPS for the quarter, missing analysts' consensus estimates of $0.09 by ($0.04). Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. The business's quarterly revenue was up 5.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.06 EPS. As a group, analysts forecast that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.
Azenta Profile
(
Free Report)
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Read More

Before you consider Azenta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.
While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.